Gangyin Zhao
PhD candidate
- Name
- Dr. G. Zhao
- Telephone
- +31 71 527 4916
- g.zhao@biology.leidenuniv.nl
.
Supervisor(s)
PhD candidate
- Faculty of Science
- Institute of Biology Leiden
- IBL Animal sciences & health
- Zhao G., Zeng Y., Cheng W., Karkampouna S., Papadopoulou P., Hu B., Zang S., Wezenberg E.J.M., Forn Cuni G., Lopes Bastos B.M., Kruithof de Julio M., Kros A. & Snaar B.E. (2025), Peptide-modified lipid nanoparticles boost the antitumor efficacy of RNA therapeutics, ACS Nano 19(14): 13685-13704.
- Zhang L., Zhao G., Dalrymple T., Husiev Y., Bronkhorst H., Fom-Cuni G., Lopes-Bastos B.M., Snaar-Jagalska B.E. & Bonnet S.A: (2024), Cyclic ruthenium-peptide prodrugs penetrate the blood–brain barrier and attack glioblastoma upon light activation in orthotopic zebrafish tumor models, ACS Central Science 10(12): 2294-2311.
- Zhao G., Forn Cuní G., Scheers M., Lindenberg P.P., Yin J., Loosen Q. van, Passarini L., Chen L. & Snaar-Jagalska B.E. (2024), Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer, Cancer Letters 587: 216657.
- Zhang L., Wang P., Zhou X.Q., Bretin L.R., Zeng X., Husiev Y., Polanco Rivas E.A., Zhao G., Wijaya L.S., Biver T., Le Dévédec S.E., Sun W. & Bonnet S. (2023), Cyclic ruthenium-peptide conjugates as integrin-targeting phototherapeutic prodrugs for the treatment of brain tumors, Journal of the American Chemical Society 145(27): 14963-14980.
- Zhao G. (5 December 2023), Exploring the mechanisms of metastatic onset for novel treatment strategies (Dissertatie. Institute of Biology Leiden (IBL), Faculty of Science, Leiden University). Supervisor(s) and Co-supervisor(s): Snaar-Jagalski B.E. & Kruithof-deJulio M., Chen L.
No relevant ancillary activities